SNN · Smith & Nephew PLC · Metrics
$30.17
+0.34 (+1.14%)
At close · Nov 20
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Market Cap
$12.47B
Shares
418.11M
Volume · Nov 19
1.16M
Avg daily vol (3M)
1.54M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
SNN metrics
77 of 125 screener metrics currently available.
Market overview
2 metricsShare price
$29.83
Market cap
$12.47B
Price action
23 metricsPrice change (1W)
-3.8%
Price change (30D)
+1.7%
Price change (3M)
+2.7%
Price change (6M)
-3.0%
Price change (YTD)
-9.1%
Price change (1Y)
-7.6%
Trailing year
Price change (5Y)
-13.9%
52-week high
$36.90
52-week low
$26.42
Change from 52-week high
-19.2%
Change from 52-week low
+12.9%
Annualized volatility
27.4%
Annualized volatility (3M)
27.6%
Implied volatility (30D)
29.4%
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
0.3
RSI (14D)
46.6
Price vs SMA 50
+3.2%
Price vs SMA 200
-3.4%
Avg volume (3M)
1.54M
Relative volume
0.8
Average dollar volume
$44.65M
Company
3 metricsSector
Healthcare
Industry
Medical Devices
Shares outstanding
418.11M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
2.0×
reciprocal yield 50.5%
P / book
2.4
reciprocal yield 41.5%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
9.3
reciprocal yield 10.7%
Earnings yield
5.1%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
2.7%
Trailing 12 months
Payout ratio
52.4%
Shareholder yield
2.7%
Dividend / share (TTM)
$0.79
Dividend growth YoY
+4.2%
Dividend growth streak
1
Last ex-dividend
2026-10-02
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-04
Profitability
9 metricsGross margin
68.2%
Operating margin
12.9%
Trailing 12 months
Net margin
10.1%
Gross profit (TTM)
$4.30B
Operating profit (TTM)
$813.00M
Net income (TTM)
$635.00M
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
20.3%
Growth
11 metricsRevenue growth YoY
+6.1%
Year over year
Net income growth YoY
+51.7%
Revenue (TTM)
$6.30B
Trailing 12 months
EPS growth YoY
+52.3%
Shares change YoY
+0.0%
Year over year · more shares
Revenue CAGR (3Y)
+5.7%
Revenue CAGR (5Y)
+6.2%
EPS CAGR (3Y)
+41.1%
EPS CAGR (5Y)
+6.9%
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
12.3%
Return on assets
5.8%
Debt / equity
—
Current ratio
2.1
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
1.1
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$754.00M
Total assets
$11.01B
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
$1.34B
Capital expenditures (TTM)
—
R&D (TTM)
$303.00M
SG&A (TTM)
—
Stock compensation (TTM)
$56.00M
R&D / revenue
4.8%
Stock compensation / revenue
0.9%
Ownership (13F)
9 metrics13F filers
261
13F filer change QoQ
-37
Institutional ownership
8.3%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-11.1%
Holder tenure
16.9
Price vs estimated holder cost
-11.9%
Ownership (registered funds)
1 metricsIndex-fund ownership
0.0%
Short interest
3 metricsShort interest
1.1%
Latest settlement · 3.7 days to cover
Days to cover
3.7d
Short-squeeze score
53 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—
Key facts
CIK
845982
CUSIP
83175M205
13F (30d)
261 filings
229 filers
Visit website
Investor relations